Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Monte Rosa Therapeutics (GLUE) Tax Rate (2023 - 2025)

Monte Rosa Therapeutics (GLUE) has 3 years of Tax Rate data on record, last reported at 10.5% in Q3 2025.

  • For Q3 2025, Tax Rate rose 1080.0% year-over-year to 10.5%; the TTM value through Sep 2025 reached 4.62%, up 494.0%, while the annual FY2024 figure was 3.66%, 341.0% down from the prior year.
  • Tax Rate reached 10.5% in Q3 2025 per GLUE's latest filing, up from 11.0% in the prior quarter.
  • Across five years, Tax Rate topped out at 13.91% in Q4 2024 and bottomed at 11.0% in Q2 2025.
  • Average Tax Rate over 3 years is 1.27%, with a median of 0.31% recorded in 2024.
  • Peak YoY movement for Tax Rate: skyrocketed 1384bps in 2024, then crashed -1022bps in 2025.
  • A 3-year view of Tax Rate shows it stood at 0.07% in 2023, then surged by 20937bps to 13.91% in 2024, then decreased by -25bps to 10.5% in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Rate were 10.5% in Q3 2025, 11.0% in Q2 2025, and 1.68% in Q1 2025.